Whether he’s cracking a whip as Indiana Jones or piloting the Millennium Falcon as Han Solo, Ford has built a reputation as someone who doesn’t sugarcoat things. So, when the conversation turned to ...

Despite launching almost six years ago, the Valve Index is still able to keep up with many of today’s PC VR headsets. Of course, there have been plenty of headsets since then, including cheaper ...

Once you have made the decision to have heart valve replacement surgery, you, along with your surgeon, will need to decide what type of replacement valve is best for you. There are several types of ...

as well as leather covers for the seats and a nifty new paint job for the grille and bumpers. In comparison to a standard Ford F-Series truck, a Black Widow represents a significant leap in cost ...

With premier position in one of the Inner-North's most prized pockets, close to transport, great local shops and quality schools, this welcoming family home sits astride a generous 981m2 parcel of ...

The Ford Fairmont came from what can largely be agreed to be a complete black hole in the history of ... step cousin the 4.6-liter modular three-valve V8 finds its way under this Fairmont.

Critics slammed New York Magazine for cropping black people out of a photo of a pro-Trump party it ran on its cover this week — with the story inside claiming that the crowd was almost entirely ...

While the "entire room is White" quote came from an unnamed attendee in the report, another influencer shared a similar claim that the involvement of Black people at the event was deliberately ...

The 1965 Mustang debuted with a 289-cube motor as the only V8 offered, but the 4.7-liter small-block lacked the muscle to put the little Ford in the ... and Cobra valve covers tell the resto ...

The Black co-host of the pictured event is calling it "insane" that he was removed from the picture of the event in Washington, D.C. on the eve of Trump's inauguration. By Kevin Dolak New York ...

Metsera has set its sights on a hefty $289 million IPO as the next-gen obesity biotech seeks to fund a phase 3 trial of its GLP-1 receptor agonist. The New York-based company disclosed plans ...